We talked to Prof. Silvio Festinese, Lecturer in Pharmacology at UniCamillus University  They cost less than their ‘brand-name cousins’, boast the same therapeutic efficacy, are equally subject to strict controls, and are available even for less common diseases, as well as for chronic ones, where a certain continuity of treatment is required. Despite all these...Read More